Can a diabetes drug tame blood sugar swings after bariatric surgery?
Disease control
ENROLLING_BY_INVITATION
This phase 2 trial tests whether dapagliflozin, a diabetes drug, can reduce dangerous blood sugar highs and lows in people who have had bariatric surgery. The study will enroll 30 participants, both with and without type 2 diabetes, and monitor glucose levels continuously for 12 …
Phase: PHASE2 • Sponsor: Dasman Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC